Cattani (Sanofi): New Frontier Site of Anagni in Rare Diseases
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
Strengthening the competitiveness of the Italian and European pharmaceutical industry, creating the conditions for attracting investment, creating innovation, accompanying
(Adnkronos) - "The site Sanofi of Anagni boasts a historical tradition in lyophiles, liquids and today is approaching the world of rare diseases, in
(Adnkronos) "That of Sanofi a Anagni is a site of excellence, that over time has been able to evolve towards more modern forms of production and more compatible with the environment. 80% of the production realized here reaches 90 Countries, a data that reflects the value of a sector in which 75% of the turnover, equal to 75 [...]
Focusing on innovation, sustainability and skills to attract new investments and strengthen the competitiveness of the Italian and European pharmaceutical industry. This is what emerged from the meeting promoted by Sanofi in the Anagni plant, in the province of Frosinone, which brought together national and territorial institutions, companies and representatives of the Life Sciences chain. At the center of the comparison the role of advanced pha…
Cattani (Sanofi): □ Collaborate with Institutions to Export Health to the World and Create Value For
We need to enhance the spirit of collaboration with local and national institutions, with a common objective: to create and export health to 90 countries of the world from the Sanofi plant. Working in close contact with the administrations, we also create added value, such as qualified employment and induced employment, the highest added value of Italian industry. Marcello [...] L'articolo Cattani (Sanofi): "Collaborate with institutions to expo…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
